Worst performer was last week's Share of the Week IKA:Ilika, which dropped 8% after climbing 20% last week. Not surprising that people would take profits. A long time till I'll be in a position to consider that as these are 50% down.
OPTI:Optibiotix dropped the 4p it climbed last week and so fell 6%. That is worth £3,200 so the fact the combined portfolios only dropped £2,473 suggests there were some big gains elsewhere.
SAE:Simec Atlantis Energy had a mini revival a few weeks ago, but is starting to slip again. It fell 5% this week and is now 72% down. Still no sign of when revenues might come in, so not one I would add to even at these low prices.
MAIS:Maistro climbed 6% this week. I still think it's doomed, but now my average price has reduced massively to 6.34p I may yet salvage something. To think these once traded at 800p. Someone will have lost a hell of a lot on this one!
CAML:Central Asia Metals finally seems to be heading back in the right direction as the China trade talks are getting more optimistic. They went up 8% this week and are now at 28% profit. This is a big holding, so the rise was worth quite a lot.
TLOU:Tlou Energy gave a robust update and climbed 9% so they are only down by 32% now. I've made over £1,500 profit from my previous holdings, so do like this company and am pretty sure they will come good again. However it's high risk and I'm becoming less willing to invest in these types of venture. Granting of the Power Purchase Agreement should see them soar.
TAP:Taptica wins Share of the Week after announcing a merger which will effectively see them take over another company. They climbed by 11% but are still down 37% after the resignation of their CEO. I belive that doesn't impact the company as badly as the share price suggests, so am confident I'll be able to sell these at a profit sometime soon.
Still bouncing every week, but didn't drop as low as 2 weeks ago.
I think I have a few more months where the trend line will point upwards, but the big spike six months ago will start to have an increasing influence so the portfolio needs to get back up there.
The ISA and share accounts look like this
| Weekly Change | |||
| Cash | £42.91 | +£0 | |
| Portfolio cost | £56,971.94 | +£0 | |
| Portfolio sell value (bid price - commission) | £58,781.35 | (3.2%) | -£1,811.75 |
| Potential profits | £10,640.79 | -£1,889.55 | |
| Yr 4 Dividends | £60.50 | +£0 | |
| Yr 4 Profit from sales | £814.53 | +£0 | |
| Yr 4 Average monthly cash profit | £142.09 | (3%) | -£5.68 |
| Total Dividends | £1,298.83 | +£0 | |
| Total Profit from sales | £19,511.65 | +£0 | |
| Average monthly cash profit | £491.46 | (10.4%) | -£2.72 |
| (Sold stocks profit + Dividends - Fees / Months) |
The drop this week is pretty much all down to OPTI:Optibiotix, which isn't a surprise as it's about half my portfolio. None of the other shares stand much chance competing for attention. Losses were reduced by around £80 and performance is clinging above 10%.
Still the right side of the line
These accounts have a long history of being on the red, so this is a great sustained period of profit now. Will it become the norm?
The SIPP looks like this after week 166
| Weekly Change | |||
| Cash | £122.84 | +£0 | |
| Portfolio cost | £37,825.18 | +£0 | |
| Portfolio sell value (bid price - commission) | £42,050.68 | (11.2%) | -£723.33 |
| Potential profits | £7,932.44 | -£676.83 | |
| Yr 4 Dividends | £0 | +£0 | |
| Yr 4 Interest | £0.04 | +£0 | |
| Yr 4 Profit from sales | £0 | +£0 | |
| Yr 4 Average monthly cash profit | -£13.50 | (-0.4%) | +£1.50 |
| Total Dividends | £1,342.25 | +£0 | |
| Total Interest | £0.07 | +£0 | |
| Total Profit from sales | £10,544.92 | +£0 | |
| Average monthly cash profit | £302.13 | (9.6%) | -£1.83 |
| (Sold stocks profit + Dividends - Fees / Months) |
Good gains by the likes of CAML:Central Asia Metals and small gains from both PAF:Pan African Resources and CEY:Centamin helped reduce the impact on the profits from the OPTI:Optibiotix drop, but the rest of the portfolio lost an additional £50.
The pension transfer still hasn't shown up, but should arrive next week. Unfortunately CAML:Central Asia Metals may have climbed too much for me to want to put it there. It was a definite buy at 225p but 239p getting a bit much with it being so volatile. I might get back into CWR:Ceres Power as a lack of news has caused them to drift from over 200p to 158p. I still believe there's massive potential in using their technology for distributed power generation, so if the price stays low maybe now is the time to strike.
I'm still gutted that VRS:Versarien won't drop to a price that I'm willing to buy back in. They are so far away from being profitable that I can't justify 130p. It's just like when I got carried away with OPTI:Optibiotix being the next great thing and bought at an inflated price 3 years before they would be profitable, only to see it plummet when this sank in. I'm pretty sure the same will happen to VRS:Versarien, but it hasn't yet. My target to buy back in is when it dips below 100p, but I doubt this will coincide with a pension transfer so I may have to sell something when (or if) the time comes. I do desperately want to be a long term VRS:Versarien shareholder though.
Still looking healthy
A long history of profitability continues.
The trading account looks like this after week 132
| Weekly Change | |||
| Cash | £18.80 | +£0 | |
| Portfolio cost | £2,321.29 | +£0 | |
| Portfolio sell value (bid price - commission) | £1,476.97 | (-36.4%) | +£61.39 |
| Potential profits | £0 | +£0 | |
| Year 3 Dividends | £17.33 | +£0 | |
| Year 3 Profit | £177.06 | +£0 | |
| Yr 3 Average monthly cash profit | £30.08 | (15.6%) | -£1.12 |
| Dividends | £18.48 | +£0 | |
| Profit from sales | -£64.29 | +£0 | |
| Average monthly cash profit | -£1.50 | (-0.8%) | +£0.02 |
| (Sold stocks profit + Dividends - Fees / Months) |
The best week for a while, mainly thanks to a big rise in CAML:Central Asia Metals which is now incredibly close to being in profit, and TAP:Taptica which is recovering fast. Target price for selling CAML:Central Asia Metals is 300p and it's at 238p now and was around 348p less than a year ago, so I'm confident the target is in sight. Meanwhile TAP:Taptica needs to get to 300p just to break even, and that's only at 197p so could take a while. Target price to sell IQE:IQE is 130p and that's only 73p at the moment so a long way to go there. The other two (LION:Lionsgold and TEK:Tekcapital) are a waste of space so no point in even mentioning them.
Oooh - there's definitely a change in direction going on.
A long, long way from changing the direction of the trend line, but there's hope.
No news from OPTI:Optibiotix this week, so fingers crossed for next week. The most worrying thing was the remarkably small number of trades in OPTI:Optibiotix shares during the week. It's ripe for manipulation at the moment, so there is a little part of me that is considering sitting on the £1,000 pension transfer in cash for a bit so I can strike should there be a sudden dip in OPTI:Optibiotix or VRS:Versarien - although the CWR:Ceres Power option is going to be difficult to resist.
No comments:
Post a Comment